Aquestive Therapeutics, Inc.·4

May 7, 5:31 PM ET

BRAENDER LORI J 4

4 · Aquestive Therapeutics, Inc. · Filed May 7, 2026

Research Summary

AI-generated summary of this filing

Updated

Aquestive (AQST) Lori Braender Withholds 76,147 Shares for Taxes

What Happened

  • Lori J. Braender, Corporate Secretary (remark: former Chief Legal Officer & Chief Compliance Officer), had 76,147 shares withheld by Aquestive to satisfy tax withholding related to the vesting of Performance Stock Units (PSUs). The withholding was reported as a disposal at $4.18 per share, totaling roughly $318,294.

Key Details

  • Transaction date: 2026-05-05; Filing date: 2026-05-07 (timely filing).
  • Price used for withholding: $4.18 per share; Shares withheld/disposed: 76,147; Approximate value: $318,294.
  • Transaction code: F — shares withheld to satisfy tax withholding on vested awards (see footnote F1).
  • Shares owned after the transaction: not specified in the provided filing.
  • Remark on insider status: listed as Former Chief Legal Officer and Chief Compliance Officer.

Context

  • This was not an open-market sale but a cashless-like tax-withholding on vested PSUs: the company retained (surrendered) shares to cover Braender’s tax obligation. Such withholdings are routine and do not necessarily indicate insider sentiment about the stock.

Insider Transaction Report

Form 4
Period: 2026-05-05
BRAENDER LORI J
Corporate Secretary
Transactions
  • Tax Payment

    Common Stock

    [F1]
    2026-05-05$4.18/sh76,147$318,294366,732 total
Footnotes (1)
  • [F1]Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Performance Stock Units ("PSUs") previously granted to the Reporting Person.
Signature
/s/ Thomas Zalewski, as Attorney-In-Fact|2026-05-07

Documents

1 file
  • 4
    marketforms-73069.xmlPrimary

    PRIMARY DOCUMENT